Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 16.

Widmer, D S; Cheng, P F; Eichhoff, O M; Benedetta, C B; Zipser, M C; Schlegel, N C; Javelaud, D; Mauviel, A; Dummer, R; Hoek, K S (2012). Systematic classification of melanoma cells by phenotype-specific gene expression mapping. Pigment Cell & Melanoma Research, 25(3):343-353.

Zipser, M C; Eichhoff, O M; Widmer, D S; Schlegel, N C; Schoenewolf, N L; Stuart, D; Liu, W; Gardner, H; Smith, P D; Nuciforo, P; Dummer, R; Hoek, K S (2011). A proliferative melanoma cell phenotype is responsive to RAF/MEK inhibition independent of BRAF mutation status. Pigment Cell & Melanoma Research, 24(2):326-333.

Karpova, M B; Barysch, M J; Zipser, M C; Schönewolf, N; French, L E; Dummer, R (2011). Changing pathology with changing drugs: skin cancer. Pathobiology, 78(2):61-75.

Dummer, R; Kawai, K; Zipser, M C (2011). Cutaneous lymphoma. In: Dummer, R; Pittelkow, M; Iwatsuki, K; Green, A; Elwan, N M. Skin cancer - a world-wide perspective. Heidelberg, DE: Springer, 343-354.

Eichhoff, O M; Weeraratna, A; Zipser, M C; Denat, L; Widmer, D S; Xu, M; Kriegl, L; Kirchner, T; Larue, L; Dummer, R; Hoek, K S (2011). Differential LEF1 and TCF4 expression is involved in melanoma cell phenotype switching. Pigment Cell & Melanoma Research, 24(4):631-642.

Zipser, M C; Dummer, R (2011). Epidemiology of histocytoses. In: Dummer, R; Pittelkow, M R; Iwatsuki, K; Green, A; Elwan, N M. Skin cancer - a world-wide perspective. Heidelberg, DE: Springer, 33-34.

Kiessling, M K; Oberholzer, P A; Mondal, C; Karpova, M B; Zipser, M C; Lin, W M; Girardi, M; MacConaill, L E; Kehoe, S M; Hatton, C; French, L E; Garraway, L A; Polier, G; Süss, D; Klemke, C D; Krammer, P H; Gülow, K; Dummer, R (2011). High-throughput mutation profiling of CTCL samples reveals KRAS and NRAS mutations sensitizing tumors toward inhibition of the RAS/RAF/MEK signaling cascade. Blood, 117(8):2433-2440.

Kamarashev, J A; Schärer, L; Zipser, M C; Lockwood, L L; Dummer, R; Krengel, S (2011). Melanocytic tumors. In: Dummer, R; Pittelkow, M; Iwatsuki, K; Green, A; Elwan, N M. Skin cancer - a world-wide perspective. Heidelberg, DE: Springer, 169-196.

Zipser, M C; Dummer, R (2011). Pathogenesis of histiocytoses. In: Dummer, R; Pittelkow, M; Iwatsuki, K; Green, A; Elwan, N M. Skin cancer - a world-wide perspective. Heidelberg, DE: Springer, 73-74.

Sánchez-Schmidt, J M; Salgado, R; Servitje, O; Gallardo, F; Ortiz-Romero, P L; Karpova, M B; Zipser, M C; García-Muret, M P; Estrach, T; Rodríguez-Pinilla, S M; Climent, F; Suela, J; Ferreira, B I; Cigudosa, J C; Salido, M; Barranco, C; Serrano, S; Dummer, R; Solé, F; Pujol, R M; Espinet, B (2011). Primary cutaneous CD30+ anaplastic large-cell lymphomas show a heterogeneous genomic profile: an oligonucleotide arrayCGH approach. Journal of Investigative Dermatology, 131(1):269-271.

Zipser, M C; Mangana, J; Oberholzer, P A; French, L E; Dummer, R (2010). Melanoma after laser therapy of pigmented lesions - circumstances and outcome. European Journal of Dermatology, 20(3):334-338.

Schad, K; Baumann Conzett, K; Zipser, M C; Enderlin, V; Kamarashev, J; French, L E; Dummer, R (2010). Mitogen-activated protein/extracellular signal-regulated kinase kinase inhibition results in biphasic alteration of epidermal homeostasis with keratinocytic apoptosis and pigmentation disorders. Clinical Cancer Research, 16(3):1058-1064.

Eichhoff, O M; Zipser, M C; Xu, M; Weeraratna, A T; Mihic, D; Dummer, R; Hoek, K S (2010). The immunohistochemistry of invasive and proliferative phenotype switching in melanoma: a case report. Melanoma Research, 20(4):349-355.

Salgado, R; Servitje, O; Gallardo, F; Vermeer, M H; Ortiz-Romero, P L; Karpova, M B; Zipser, M C; Muniesa, C; García-Muret, M P; Estrach, T; Salido, M; Sánchez-Schmidt, J; Herrera, M; Romagosa, V; Suela, J; Ferreira, B I; Cigudosa, J C; Barranco, C; Serrano, S; Dummer, R; Tensen, C P; Solé, F; Pujol, R M; Espinet, B (2009). Oligonucleotide array-cgh identifies genomic subgroups and prognostic markers for tumor stage mycosis fungoides. Journal of Investigative Dermatology, 130(4):1126-1135.

Emery, C M; Vijayendran, K G; Zipser, M C; Sawyer, A M; Niu, L; Kim, J J; Hatton, C; Chopra, R; Oberholzer, P A; Karpova, M B; MacConaill, L E; Zhang, J; Gray, N S; Sellers, W R; Dummer, R; Garraway, L A (2009). MEK1 mutations confer resistance to MEK and B-RAF inhibition. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 106(48):20411-20416.

Mangana, J; Zipser, M C; Conrad, C; Oberholzer, P A; Cozzio, A; Knuth, A; French, L E; Dummer, R (2008). Skin problems associated with pegylated liposomal doxorubicin-more than palmoplantar erythrodysesthesia syndrome. European Journal of Dermatology, 18(5):566-570.

This list was generated on Sat Dec 16 17:05:12 2017 CET.